Abstract
Osteosarcoma (OS) is the most common primary malignancy of skeleton with higher mortality rates amongst children and young adults worldwide, whereas effective and secure therapies have also been sought by researches with ongoing efforts. The purpose of the present study was to investigate the impact of N′-[(3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene] benzohydrazide (MDA19) on OS and explore its potential mechanism. Cell Counting Kit-8 (CCK8) and colony formation assay were employed to evaluate the potential effect of MDA19 on U2OS and MG-63 cells proliferation. Moreover, transwell migration and invasion assay were performed to assess the influence of MDA19 on U2OS and MG-63 cells migration and invasion. In addition, Annexin V-FITC/propidium iodide (Annexin V-FITC/PI) staining and flow cytometry were used to examine apoptotic ratio of the U2OS and MG-63 cells. Meanwhile, Western blot analysis was applied to explore change of relevant mechanism proteins in OS cells treated with MDA19. Our study showed that MDA19 had anti-proliferative activity of OS cells in a dose- and time-dependent manner, simultaneously, inhibition of colony formation was also observed in U2OS and MG-63 cells after incubation of MDA19. Besides, MDA19 could significantly inhibit the number of migrated and invaded OS cells and markedly increase the OS cells apoptosis rate. Mechanistically, we detected detectable reductions in apoptosis related proteins, epithelial–mesenchymal transition (EMT)-related proteins and activity of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling in U2OS and MG-63 cells exposure to MDA19. Overall, the current study indicates in vitro anti-proliferative, anti-metastatic, and pro-apoptotic potential of MDA19 in U2OS and MG-63 cells. Our findings propose a clue for further studies with this compound in preclinical and clinical treatment for OS.
Highlights
Osteosarcoma (OS), termed as osteogenic sarcoma, is the most common malignant bone tumor worldwide, marked by malignant tumor cells directly form bone tissue and mainly harming children and young adults [1,2]
We determined cells’ viability by measuring optical density (OD) value after U2OS and MG-63 cells treated with N -[(3Z)-1-(1-hexyl)-2-oxo-1 (MDA19) at 0, 1, 2.5, 5, 10, 20, 50, 100, 200 μM and examined that the inhibitory effect of MDA19 on OS cells’ viability was in a concentration-dependent manner
For detection of OS cells proliferation by colony formation assay, we found that number of colonies of U2OS and MG-63 cells were markedly reduced in MDA19 groups comparable with negative control groups (NC) groups (Figure 1C, F (8, 18) = 85.396, Figure 1C, F (8, 18) = 52.296, **P
Summary
Osteosarcoma (OS), termed as osteogenic sarcoma, is the most common malignant bone tumor worldwide, marked by malignant tumor cells directly form bone tissue and mainly harming children and young adults [1,2]. Standard therapies of OS encompass surgical operation, neoadjuvant and adjuvant chemotherapy. Surgical operation has resulted in amputations, neoadjuvant or adjuvant chemotherapy have induced toxic effect(s) unable to be prevented efficiently, albeit these strategies have improved survival rate of patients, while an overall 5-year survival rate is still disappointingly low (below 30%) in patients with relapse and metastasis [3,4]. Identification and validation of some pharmaceutical-targetted therapies against protein molecules or other biomarkers in OS still is imperative c 2018 The Author(s). Little report is recently available for the role of N -[(3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene] benzohydrazide (MDA19) in anti-tumoral effect of OS
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
